| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 5.3 | $5k-$25k | 0.00 |
Summary
A vulnerability identified as critical has been detected in IBM TRIRIGA Application Platform 3/3/3.3/4/5. Affected by this vulnerability is an unknown functionality. The manipulation leads to access control. This vulnerability is listed as CVE-2017-1171. The attack may be initiated remotely. There is no available exploit.
Details
A vulnerability was found in IBM TRIRIGA Application Platform 3/3/3.3/4/5 (Service Management Software). It has been rated as critical. This issue affects some unknown functionality. The manipulation with an unknown input leads to a access control vulnerability. Using CWE to declare the problem leads to CWE-284. The product does not restrict or incorrectly restricts access to a resource from an unauthorized actor. Impacted is confidentiality, integrity, and availability. The summary by CVE is:
The IBM TRIRIGA Application Platform 3.3, 3,4, and 3,5 contain a vulnerability that could allow an authenticated user to execute Application actions they do not have access to. IBM Reference #: 2001083.
The bug was discovered 03/28/2017. The weakness was presented 03/31/2017 (Website). It is possible to read the advisory at ibm.com. The identification of this vulnerability is CVE-2017-1171 since 11/30/2016. The attack may be initiated remotely. A simple authentication is required for exploitation. The technical details are unknown and an exploit is not publicly available. The attack technique deployed by this issue is T1068 according to MITRE ATT&CK.
The vulnerability was handled as a non-public zero-day exploit for at least 3 days. During that time the estimated underground price was around $5k-$25k.
There is no information about possible countermeasures known. It may be suggested to replace the affected object with an alternative product.
The vulnerability is also documented in the vulnerability database at SecurityFocus (BID 97245†). Be aware that VulDB is the high quality source for vulnerability data.
Product
Type
Vendor
Name
Version
License
Website
- Vendor: https://www.ibm.com/
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔍VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 5.3VulDB Meta Temp Score: 5.3
VulDB Base Score: 6.3
VulDB Temp Score: 6.3
VulDB Vector: 🔍
VulDB Reliability: 🔍
NVD Base Score: 4.3
NVD Vector: 🔍
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔍
VulDB Temp Score: 🔍
VulDB Reliability: 🔍
NVD Base Score: 🔍
Exploiting
Class: Access controlCWE: CWE-284 / CWE-266
CAPEC: 🔍
ATT&CK: 🔍
Physical: No
Local: No
Remote: Yes
Availability: 🔍
Status: Not defined
EPSS Score: 🔍
EPSS Percentile: 🔍
Price Prediction: 🔍
Current Price Estimation: 🔍
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: no mitigation knownStatus: 🔍
0-Day Time: 🔍
Timeline
11/30/2016 🔍03/28/2017 🔍
03/28/2017 🔍
03/31/2017 🔍
03/31/2017 🔍
04/01/2017 🔍
08/24/2020 🔍
Sources
Vendor: ibm.comAdvisory: ibm.com
Status: Not defined
Confirmation: 🔍
CVE: CVE-2017-1171 (🔍)
GCVE (CVE): GCVE-0-2017-1171
GCVE (VulDB): GCVE-100-99143
SecurityFocus: 97245 - IBM TRIRIGA Application Platform CVE-2017-1171 Unspecified Remote Privilege Escalation Vulnerability
OSVDB: - CVE-2017-1171 - IBM - TRIRIGA Application Platform - Privilege Escalation Issue
Entry
Created: 04/01/2017 10:03Updated: 08/24/2020 12:23
Changes: 04/01/2017 10:03 (60), 08/24/2020 12:23 (5)
Complete: 🔍
Cache ID: 216::103
Be aware that VulDB is the high quality source for vulnerability data.
No comments yet. Languages: en.
Please log in to comment.